Encompass Health (NYSE:EHC) Updates FY24 Earnings Guidance

Encompass Health (NYSE:EHC) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $3.86-4.11 for the period, compared to the consensus earnings per share estimate of $3.98. The company issued revenue guidance of $5.250-5.325 billion, compared to the consensus revenue estimate of $5.25 billion.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Royal Bank of Canada reissued an outperform rating and set a $83.00 price objective on shares of Encompass Health in a report on Friday, February 9th. Stephens reissued an overweight rating and set a $85.00 price objective on shares of Encompass Health in a report on Tuesday, January 16th. William Blair reissued an outperform rating on shares of Encompass Health in a report on Wednesday, February 7th. Barclays upped their target price on Encompass Health from $95.00 to $101.00 and gave the stock an overweight rating in a research note on Thursday, March 28th. Finally, Mizuho upped their target price on Encompass Health from $77.00 to $82.00 and gave the stock a buy rating in a research note on Friday, February 9th. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of Buy and an average target price of $83.22.

Encompass Health Trading Up 0.3 %

Shares of NYSE:EHC traded up $0.26 during trading on Wednesday, reaching $82.72. 1,216,634 shares of the company traded hands, compared to its average volume of 662,203. The firm has a market capitalization of $8.28 billion, a price-to-earnings ratio of 23.84, a P/E/G ratio of 1.49 and a beta of 0.94. Encompass Health has a 52-week low of $57.55 and a 52-week high of $83.73. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.19. The business’s fifty day moving average is $77.89 and its 200-day moving average is $70.67.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, February 7th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.83 by $0.12. The company had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. As a group, analysts forecast that Encompass Health will post 3.96 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were issued a dividend of $0.15 per share. The ex-dividend date was Thursday, March 28th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.73%. Encompass Health’s dividend payout ratio is presently 17.29%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.